Reducing Filth Fly Populations and Transmission of Diarrhoeal Pathogens in Harsh Settings
Recruiting
Phase 3
Interventional Study
Diarrheal Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 1 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 5,556 (estimated)
- Sponsor
- The Mentor Initiative · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Objectives The main trial objective is to evaluate the efficacy of larvicide (LARV) or baited fly traps (TRAP), or both interventions combined, on filth fly density and hence transmission of diarrhoeal diseases.
Primary Objective
• To evaluate the efficacy of LARV or TRAP, or both interventions combined, in reducing the number of cases of all-cause diarrhoea (primary epidemiological endpoint).
…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Individuals of either ≤5 years old or ≥15 years old all ages
* Slept in camp ≥27 nights during any given month
* Individual is not severely malnourished, sick, anemic (self-reported), has signs of clinical decompensation, and/or has any other chronic co-morbidities (e.g. HIV o…
Contacts